Skip to main content
. 2023 May 19;19(8):539–546. doi: 10.1200/OP.22.00480

FIG 1.

FIG 1.

(A) Monitoring and management of pneumonitis/ILD associated with T-DXd treatment per the DESTINY-Breast03 and DESTINY-Breast04 protocols.7,9 (B) Diagnostic algorithm for T-DXd–induced pneumonitis/ILD.7,9 ABG, arterial blood gas; BAL, bronchoalveolar lavage; HRCT, high-resolution computerized tomography; ILD, interstitial lung disease; PFT, pulmonary function test; SpO2, peripheral oxygen saturation; T-DXd, trastuzumab deruxtecan.